Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin- 12

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1307-1312

  Kawakami, Kazuyoshi ^a   Tohyama, Masaki ^a   Qifeng, Xie ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION; HELPER CELL; HOST RESISTANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; INTERFERON PRODUCTION; LUNG MYCOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CRYPTOCOCCOSIS; CYTOKINES; FEMALE; INTERLEUKIN-12; LUNG; MICE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 0031004808     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Alspaugh, J. A., and D. L. Granger. 1091. Inhibition of Ctyptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
2. Belosevic, M. D., S. Finbloom, P. H. Van Der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266-274.
3. Brummer, E., and D. Stevens. 1994. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, and L-arginine. Cell. Immunol. 157:1-10.
4. Chang, C M., A. Lirnannu W. H. Baker, M. E. Dobson, J. F. Kalinkh, W. Jackson, and M. L. Patchen, 1995. Bone marrow and splenic granulocytemacrophage colony-stimulating factor and transforming growth factor-β mRNA levels in irradiated mice. Blood 86:2130-2136.
5. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Denis, M., and E. Champsi. 1993. IL-10 neutralization augments mouse resistance to systemic Mycohacteriarn avium infections. J. Immunol. 151:5425-5432.
8. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Jhonson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
9. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
10. Fernandas, D. M., and C. L. Baldwin. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect. Immun. 63:1130-1133.
11. Gazzinelli, R., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-ot and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
12. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinichieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-7 synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
13. Heinzel, F. P. 1990. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
14. Heinzel, F. P., D. S, Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
15. Hibbs, J. B. Jr., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deaminase and amino nitrogen oxidation to nitrite. Science 197:473-476.
16. Hill, J. O., and A. G. Harmsen. 1991. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med. 173:755-758.
17. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
18. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173:793-800.
19. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interteron-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000.
20. Jeannin, P., Y. Delneste, P. Life, J.-F. Gauchat, D. Kaiserlian, and J.-Y. Bonnefoy. 1995. Interleukin-12 increases interleukin-4 production by established human Th0 and Th2-like T cell clones. Eur. J. Immunol. 25:2247- 2252.
21. Kawakami, K., Y. Yamamoto, K. Kakimoto, and K. Onoue. 1989. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN - y modulation of accessory cells for physical interaction with T cells. J. Immunol. 142:1818-1825.
22. Kawakami, K., M. Tohyama, K. Teruya, N. Kudeken, Q. Xie, and A. Saito. 1996. Contribution of interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 13:123-130.
23. Kawakami, K., M. Tohyama, Q. Xie, and A. Saito. 1996. Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208-214.
24. Kiener, P. A., F. Marek, G. Rodgers, P. F. Lin, G. Warr, and J- Desiderio. 1988. Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. J. Immunol. 141:870-874.
25. Leal, L., D. Moss, R, Kuhn, W. Muller, and F. Liew. 1993. lnterleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23:566-569.
26. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvauv D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Intcrleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
27. Mcknight, A. J., G. J. Zimmer, I. Fogelman, S. F, Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172-2179.
28. Meyaard, L., E. Hovenkamp, S. A. Otto, and F. Miedema. 1996. IL-12indueed IL-IO production by human T cells as a negative feedback for IL-12-induccd immune responses. J. Immunol. 156:2776-2782.
29. Mody, C. H., M. F. Lipscomb, N. E. Street, and G. B. Toews. 1990. Depletion of CD4 + (L3T4+) lymphocytes in vivo impairs murinc host defense to Cryptococcus neoformans. J. Immunol. 144:1472-1477.
30. Montgomery, R., and M. J. Dallman. 1991. Analysis of cytokine gene expression during fetal ihymic ontogeny using the polymerase chain reaction. J. Immunol. 147:554-560.
31. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1. Th2 and more. Immunol. Today 17:138-146.
32. Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-/pr//pr mouse. Eur. J. Immunol. 20:163-170.
33. Nathan, C. 1992. Nilric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
34. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91.
35. Romani, L., A. Mencacci, L. Tonnetti, R, Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153: 5167-5175.
36. Ruegemer, J. J., S. N. Ho, J. A. Augustine, J. W. Schlager, M. P. Bell, D. J. McKean, and R. T. Abraham. 1990. Regulatory effects of transforming growth factor βon 1L-2- and IL-4-dependent T cell cycle progression. J. Immunol. 144:1767-1776.
37. Salkowski, C. A., and E. Balish. 1991. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococeosis. Infect. Immun. 59:486-493.
38. Schmitt, E., P. Hoehn, T. Germann, and E. Rude. 1994. Differential effects of mterleukin-12 on the development of naive mouse CD4+ T cells. Eur. J. Immunol. 24:343-347.
39. Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rude, and T. Germann. 1994. Thelper type 1 development of naive CD4+ T cells requires the cordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793-798.
40. Scott, P., and S. H. E. Kaufmann. 1991. The role of T-cell subsets and cvtokines in the regulation of infections. Immunol. Today 12:346-348.
41. Siepl, C., S. Bodmer, K. Frei, H. R. MacDonald, R. DcMartin, E. Hofer, and A. Fontana. 1988. The glioblastoma-derived T cell suppression factor/transforming growth factor-β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor. Eur. J. Immunol. 18:593-600.
42. Silva, J. S., P. J. Morrissey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and intcrferon -γ regulation of experimental Tiypanozoma cruzi infection. J. Exp. Med. 175:169-174.
43. Skeen, M. J., and H. K. Ziegler. 1995. Activation of γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines 1L-1 and IL-12. J. Immunol. 154:5832-5841.
44. Stevens, D. A. 1990. Fungal infections in AIDS patients, Br. J. Clin. Practice 44(Suppl.1):11-22.
45. Tohyama, M., K. Kawakami, M. Futenma, and A. Saito. 1996. Enhancing effect of oxygen radical scavengers on anticryptococcal activity of murine peritoneal macrophages through production of nitric Oxide. Clin. Exp. Immunol. 103:436-441.
46. Trinchieri, G. 1995. fnterfeukin-12: a proinflammatory cytokme with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
47. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice. J. Immunol. 152:1883-1887.
48. Ushio, S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, K. Torigoe, T. Tanimoto, S. Fukuda, M. Ikeda, H, Okamura, and M. Kurimoto. 1996. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichict coli, and studies on the biologie activities of the protein. J. Immunol. 156:4274-4279.
49. Wang, Z., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91:12932-12936.
50. Wynn, T. A., D. Jankovic, S. Hieny, K, Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154: 3999-4009.
51. Yoshida, A., Y. Koide, M. Uchijima, and T. O. Yoshida. 1994. IFN-γ induces IL-32 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophy. Res. Commun. 198:857-861.